Unresolved disorder model. using A ATOM 41 CA AGLN 6 25.947 -21.060 3.301 0.50 19.58 C Unresolved disorder model. using A ATOM 42 CA BGLN 6 25.954 -21.054 3.286 0.50 20.10 C Unresolved disorder model. using A ATOM 45 CB AGLN 6 25.630 -20.675 4.749 0.50 18.83 C Unresolved disorder model. using A ATOM 46 CB BGLN 6 25.666 -20.613 4.720 0.50 19.62 C Unresolved disorder model. using A ATOM 47 CG AGLN 6 26.508 -21.404 5.783 0.50 19.14 C Unresolved disorder model. using A ATOM 48 CG BGLN 6 26.807 -20.892 5.691 0.50 22.60 C Unresolved disorder model. using A ATOM 49 CD AGLN 6 27.919 -20.829 5.868 0.50 19.31 C Unresolved disorder model. using A ATOM 50 CD BGLN 6 26.851 -19.898 6.839 0.50 24.09 C Unresolved disorder model. using A ATOM 51 OE1AGLN 6 28.914 -21.545 5.702 0.50 20.98 O Unresolved disorder model. using A ATOM 52 OE1BGLN 6 26.168 -18.868 6.825 0.50 29.21 O Unresolved disorder model. using A ATOM 53 NE2AGLN 6 28.009 -19.527 6.123 0.50 19.01 N Unresolved disorder model. using A ATOM 54 NE2BGLN 6 27.656 -20.200 7.841 0.50 26.79 N Unresolved disorder model. using A ATOM 56 CA ALEU 7 27.360 -24.576 3.014 0.60 19.59 C Unresolved disorder model. using A ATOM 57 CA BLEU 7 27.378 -24.573 2.993 0.40 20.28 C Unresolved disorder model. using A ATOM 60 CB ALEU 7 28.560 -24.989 2.184 0.60 20.05 C Unresolved disorder model. using A ATOM 61 CB BLEU 7 28.594 -24.923 2.132 0.40 20.71 C Unresolved disorder model. using A ATOM 62 CG ALEU 7 28.421 -24.803 0.686 0.60 18.37 C Unresolved disorder model. using A ATOM 63 CG BLEU 7 28.751 -26.242 1.369 0.40 22.10 C Unresolved disorder model. using A ATOM 64 CD1ALEU 7 29.726 -25.182 0.067 0.60 19.50 C Unresolved disorder model. using A ATOM 65 CD1BLEU 7 27.521 -26.595 0.530 0.40 22.43 C Unresolved disorder model. using A ATOM 66 CD2ALEU 7 27.276 -25.716 0.196 0.60 21.10 C Unresolved disorder model. using A ATOM 67 CD2BLEU 7 29.982 -26.171 0.469 0.40 20.59 C Unresolved disorder model. using A ATOM 165 CA AVAL 21 21.111 -22.922 3.474 0.50 18.95 C Unresolved disorder model. using A ATOM 166 CA BVAL 21 21.088 -22.946 3.439 0.50 18.55 C Unresolved disorder model. using A ATOM 169 CB AVAL 21 21.288 -22.686 5.006 0.50 19.26 C Unresolved disorder model. using A ATOM 170 CB BVAL 21 21.113 -22.853 4.998 0.50 18.87 C Unresolved disorder model. using A ATOM 171 CG1AVAL 21 19.989 -22.143 5.617 0.50 19.66 C Unresolved disorder model. using A ATOM 172 CG1BVAL 21 22.458 -22.380 5.475 0.50 17.42 C Unresolved disorder model. using A ATOM 173 CG2AVAL 21 21.680 -23.954 5.687 0.50 19.67 C Unresolved disorder model. using A ATOM 174 CG2BVAL 21 19.976 -21.942 5.512 0.50 18.83 C Unresolved disorder model. using A ATOM 242 CA AGLU 31 22.244 -34.607 0.054 0.50 17.39 C Unresolved disorder model. using A ATOM 243 CA BGLU 31 22.239 -34.600 0.051 0.50 17.66 C Unresolved disorder model. using A ATOM 246 CB AGLU 31 22.973 -34.489 -1.308 0.50 16.86 C Unresolved disorder model. using A ATOM 247 CB BGLU 31 22.984 -34.452 -1.295 0.50 17.28 C Unresolved disorder model. using A ATOM 248 CG AGLU 31 24.407 -33.938 -1.258 0.50 15.36 C Unresolved disorder model. using A ATOM 249 CG BGLU 31 22.193 -33.762 -2.461 0.50 18.16 C Unresolved disorder model. using A ATOM 250 CD AGLU 31 25.215 -34.080 -2.590 0.50 18.01 C Unresolved disorder model. using A ATOM 251 CD BGLU 31 20.913 -34.508 -2.873 0.50 18.31 C Unresolved disorder model. using A ATOM 252 OE1AGLU 31 24.646 -34.237 -3.719 0.50 16.58 O Unresolved disorder model. using A ATOM 253 OE1BGLU 31 20.844 -35.727 -2.666 0.50 19.87 O Unresolved disorder model. using A ATOM 254 OE2AGLU 31 26.455 -33.989 -2.504 0.50 16.65 O Unresolved disorder model. using A ATOM 255 OE2BGLU 31 19.961 -33.886 -3.388 0.50 19.26 O Unresolved disorder model. using A ATOM 365 CA ALEU 46 26.436 -27.232 -9.775 0.70 15.52 C Unresolved disorder model. using A ATOM 366 CA BLEU 46 26.444 -27.252 -9.766 0.30 15.42 C Unresolved disorder model. using A ATOM 369 CB ALEU 46 27.146 -28.243 -10.688 0.70 16.15 C Unresolved disorder model. using A ATOM 370 CB BLEU 46 27.167 -28.304 -10.606 0.30 15.63 C Unresolved disorder model. using A ATOM 371 CG ALEU 46 28.600 -27.905 -11.042 0.70 16.43 C Unresolved disorder model. using A ATOM 372 CG BLEU 46 26.969 -28.376 -12.117 0.30 15.93 C Unresolved disorder model. using A ATOM 373 CD1ALEU 46 29.325 -29.142 -11.685 0.70 17.71 C Unresolved disorder model. using A ATOM 374 CD1BLEU 46 27.222 -27.042 -12.822 0.30 15.97 C Unresolved disorder model. using A ATOM 375 CD2ALEU 46 28.636 -26.720 -11.972 0.70 18.15 C Unresolved disorder model. using A ATOM 376 CD2BLEU 46 27.882 -29.463 -12.656 0.30 15.47 C Unresolved disorder model. using A ATOM 378 CA ALYS 47 23.058 -28.799 -8.837 0.50 14.54 C Unresolved disorder model. using A ATOM 379 CA BLYS 47 23.058 -28.779 -8.891 0.50 15.01 C Unresolved disorder model. using A ATOM 382 CB ALYS 47 22.887 -29.958 -7.875 0.50 14.51 C Unresolved disorder model. using A ATOM 383 CB BLYS 47 22.821 -30.072 -8.126 0.50 14.99 C Unresolved disorder model. using A ATOM 384 CG ALYS 47 23.468 -31.279 -8.356 0.50 15.07 C Unresolved disorder model. using A ATOM 385 CG BLYS 47 22.991 -31.328 -9.015 0.50 15.94 C Unresolved disorder model. using A ATOM 386 CD ALYS 47 22.875 -32.420 -7.559 0.50 13.19 C Unresolved disorder model. using A ATOM 387 CD BLYS 47 22.689 -32.652 -8.300 0.50 16.30 C Unresolved disorder model. using A ATOM 388 CE ALYS 47 23.665 -32.721 -6.316 0.50 11.29 C Unresolved disorder model. using A ATOM 389 CE BLYS 47 21.190 -32.834 -8.051 0.50 20.01 C Unresolved disorder model. using A ATOM 390 NZ ALYS 47 23.055 -33.918 -5.711 0.50 15.05 N Unresolved disorder model. using A ATOM 391 NZ BLYS 47 20.830 -34.105 -7.345 0.50 22.95 N Unresolved disorder model. using A ATOM 410 CA AARG 51 18.023 -24.508 -9.498 0.80 19.12 C Unresolved disorder model. using A ATOM 411 CA BARG 51 18.033 -24.520 -9.440 0.20 18.35 C Unresolved disorder model. using A ATOM 414 CB AARG 51 17.850 -25.694 -8.514 0.80 18.95 C Unresolved disorder model. using A ATOM 415 CB BARG 51 17.931 -25.555 -8.303 0.20 18.22 C Unresolved disorder model. using A ATOM 416 CG AARG 51 17.904 -27.041 -9.271 0.80 19.84 C Unresolved disorder model. using A ATOM 417 CG BARG 51 18.224 -26.993 -8.701 0.20 18.95 C Unresolved disorder model. using A ATOM 418 CD AARG 51 18.278 -28.291 -8.425 0.80 20.69 C Unresolved disorder model. using A ATOM 419 CD BARG 51 17.682 -27.980 -7.657 0.20 18.30 C Unresolved disorder model. using A ATOM 420 NE AARG 51 18.128 -29.502 -9.233 0.80 21.72 N Unresolved disorder model. using A ATOM 421 NE BARG 51 18.440 -29.230 -7.572 0.20 19.61 N Unresolved disorder model. using A ATOM 422 CZ AARG 51 18.932 -29.894 -10.241 0.80 23.73 C Unresolved disorder model. using A ATOM 423 CZ BARG 51 18.457 -30.186 -8.501 0.20 20.44 C Unresolved disorder model. using A ATOM 424 NH1AARG 51 19.987 -29.152 -10.635 0.80 16.74 N Unresolved disorder model. using A ATOM 425 NH1BARG 51 17.768 -30.053 -9.629 0.20 21.17 N Unresolved disorder model. using A ATOM 426 NH2AARG 51 18.623 -31.011 -10.912 0.80 20.11 N Unresolved disorder model. using A ATOM 427 NH2BARG 51 19.173 -31.285 -8.305 0.20 20.32 N Unresolved disorder model. using A ATOM 473 CA AVAL 57 28.484 -19.231 -1.345 0.50 21.53 C Unresolved disorder model. using A ATOM 474 CA BVAL 57 28.503 -19.260 -1.373 0.50 20.71 C Unresolved disorder model. using A ATOM 477 CB AVAL 57 28.581 -20.608 -2.049 0.50 22.03 C Unresolved disorder model. using A ATOM 478 CB BVAL 57 28.741 -20.580 -2.142 0.50 20.99 C Unresolved disorder model. using A ATOM 479 CG1AVAL 57 29.924 -20.794 -2.748 0.50 21.92 C Unresolved disorder model. using A ATOM 480 CG1BVAL 57 29.009 -21.744 -1.183 0.50 18.91 C Unresolved disorder model. using A ATOM 481 CG2AVAL 57 28.344 -21.733 -1.046 0.50 20.41 C Unresolved disorder model. using A ATOM 482 CG2BVAL 57 27.545 -20.905 -3.052 0.50 16.80 C Unresolved disorder model. using A ATOM 650 CA ALYS 80 31.507 -15.953 -5.868 0.50 26.99 C Unresolved disorder model. using A ATOM 651 CA BLYS 80 31.501 -15.957 -5.864 0.50 26.72 C Unresolved disorder model. using A ATOM 654 CB ALYS 80 31.268 -14.515 -5.431 0.50 26.88 C Unresolved disorder model. using A ATOM 655 CB BLYS 80 31.225 -14.541 -5.413 0.50 26.46 C Unresolved disorder model. using A ATOM 656 CG ALYS 80 32.465 -13.891 -4.706 0.50 29.02 C Unresolved disorder model. using A ATOM 657 CG BLYS 80 31.078 -13.559 -6.538 0.50 27.23 C Unresolved disorder model. using A ATOM 658 CD ALYS 80 32.051 -12.670 -3.893 0.50 31.82 C Unresolved disorder model. using A ATOM 659 CD BLYS 80 31.185 -12.158 -5.979 0.50 29.20 C Unresolved disorder model. using A ATOM 660 CE ALYS 80 33.261 -11.985 -3.262 0.50 32.76 C Unresolved disorder model. using A ATOM 661 CE BLYS 80 30.446 -11.202 -6.864 0.50 30.27 C Unresolved disorder model. using A ATOM 662 NZ ALYS 80 34.093 -11.343 -4.322 0.50 32.16 N Unresolved disorder model. using A ATOM 663 NZ BLYS 80 30.139 -9.990 -6.095 0.50 31.91 N Unresolved disorder model. using A ATOM 1229 CA AILE 153 1.756 -28.375 -12.065 0.60 21.13 C Unresolved disorder model. using A ATOM 1230 CA BILE 153 1.753 -28.372 -12.058 0.40 21.20 C Unresolved disorder model. using A ATOM 1233 CB AILE 153 0.721 -28.172 -13.227 0.60 21.63 C Unresolved disorder model. using A ATOM 1234 CB BILE 153 0.718 -28.147 -13.204 0.40 21.76 C Unresolved disorder model. using A ATOM 1235 CG1AILE 153 -0.709 -28.097 -12.679 0.60 21.62 C Unresolved disorder model. using A ATOM 1236 CG1BILE 153 -0.571 -27.487 -12.674 0.40 22.45 C Unresolved disorder model. using A ATOM 1237 CG2AILE 153 0.842 -29.310 -14.254 0.60 21.07 C Unresolved disorder model. using A ATOM 1238 CG2BILE 153 0.470 -29.453 -13.963 0.40 21.32 C Unresolved disorder model. using A ATOM 1239 CD1AILE 153 -1.762 -27.736 -13.744 0.60 21.88 C Unresolved disorder model. using A ATOM 1240 CD1BILE 153 -1.499 -28.365 -11.870 0.40 25.42 C Unresolved disorder model. using A ATOM 1256 CA AGLN 155 5.285 -33.021 -15.928 0.60 19.28 C Unresolved disorder model. using A ATOM 1257 CA BGLN 155 5.266 -33.030 -15.903 0.40 19.52 C Unresolved disorder model. using A ATOM 1260 CB AGLN 155 5.156 -32.512 -17.367 0.60 18.80 C Unresolved disorder model. using A ATOM 1261 CB BGLN 155 5.018 -32.552 -17.338 0.40 19.33 C Unresolved disorder model. using A ATOM 1262 CG AGLN 155 5.325 -33.592 -18.442 0.60 20.05 C Unresolved disorder model. using A ATOM 1263 CG BGLN 155 4.647 -33.651 -18.331 0.40 21.69 C Unresolved disorder model. using A ATOM 1264 CD AGLN 155 4.135 -34.533 -18.487 0.60 21.73 C Unresolved disorder model. using A ATOM 1265 CD BGLN 155 3.885 -33.136 -19.543 0.40 22.98 C Unresolved disorder model. using A ATOM 1266 OE1AGLN 155 4.262 -35.750 -18.263 0.60 23.34 O Unresolved disorder model. using A ATOM 1267 OE1BGLN 155 3.203 -32.112 -19.484 0.40 26.78 O Unresolved disorder model. using A ATOM 1268 NE2AGLN 155 2.960 -33.970 -18.731 0.60 20.24 N Unresolved disorder model. using A ATOM 1269 NE2BGLN 155 3.986 -33.857 -20.648 0.40 26.97 N Unresolved disorder model. using A ATOM 1271 CA ALEU 156 7.605 -35.997 -15.648 0.60 19.24 C Unresolved disorder model. using A ATOM 1272 CA BLEU 156 7.582 -36.028 -15.628 0.40 19.81 C Unresolved disorder model. using A ATOM 1275 CB ALEU 156 7.407 -37.236 -14.800 0.60 19.67 C Unresolved disorder model. using A ATOM 1276 CB BLEU 156 7.255 -37.279 -14.819 0.40 20.18 C Unresolved disorder model. using A ATOM 1277 CG ALEU 156 7.322 -36.971 -13.302 0.60 18.20 C Unresolved disorder model. using A ATOM 1278 CG BLEU 156 8.282 -38.062 -13.999 0.40 20.60 C Unresolved disorder model. using A ATOM 1279 CD1ALEU 156 7.053 -38.270 -12.590 0.60 18.83 C Unresolved disorder model. using A ATOM 1280 CD1BLEU 156 9.164 -37.171 -13.103 0.40 21.37 C Unresolved disorder model. using A ATOM 1281 CD2ALEU 156 8.633 -36.301 -12.802 0.60 21.26 C Unresolved disorder model. using A ATOM 1282 CD2BLEU 156 7.544 -39.066 -13.149 0.40 20.16 C Unresolved disorder model. using A ATOM 1380 CA AVAL 170 9.256 -29.729 -16.072 0.60 18.86 C Unresolved disorder model. using A ATOM 1381 CA BVAL 170 9.282 -29.721 -16.040 0.40 17.85 C Unresolved disorder model. using A ATOM 1384 CB AVAL 170 8.957 -29.758 -17.594 0.60 19.28 C Unresolved disorder model. using A ATOM 1385 CB BVAL 170 9.193 -29.658 -17.602 0.40 18.00 C Unresolved disorder model. using A ATOM 1386 CG1AVAL 170 9.132 -28.362 -18.200 0.60 20.31 C Unresolved disorder model. using A ATOM 1387 CG1BVAL 170 8.132 -30.602 -18.136 0.40 15.04 C Unresolved disorder model. using A ATOM 1388 CG2AVAL 170 9.850 -30.742 -18.272 0.60 21.81 C Unresolved disorder model. using A ATOM 1389 CG2BVAL 170 8.932 -28.218 -18.075 0.40 17.90 C Unresolved disorder model. using A ATOM 1457 CA AGLU 180 18.814 -36.584 -12.689 0.50 17.23 C Unresolved disorder model. using A ATOM 1458 CA BGLU 180 18.813 -36.582 -12.680 0.50 17.70 C Unresolved disorder model. using A ATOM 1461 CB AGLU 180 18.389 -37.138 -11.313 0.50 16.65 C Unresolved disorder model. using A ATOM 1462 CB BGLU 180 18.364 -37.166 -11.323 0.50 17.26 C Unresolved disorder model. using A ATOM 1463 CG AGLU 180 17.118 -37.994 -11.306 0.50 15.37 C Unresolved disorder model. using A ATOM 1464 CG BGLU 180 18.161 -36.176 -10.129 0.50 18.86 C Unresolved disorder model. using A ATOM 1465 CD AGLU 180 16.914 -38.838 -10.013 0.50 17.38 C Unresolved disorder model. using A ATOM 1466 CD BGLU 180 19.422 -35.391 -9.709 0.50 18.65 C Unresolved disorder model. using A ATOM 1467 OE1AGLU 180 17.271 -38.424 -8.869 0.50 14.76 O Unresolved disorder model. using A ATOM 1468 OE1BGLU 180 20.547 -35.889 -9.883 0.50 20.28 O Unresolved disorder model. using A ATOM 1469 OE2AGLU 180 16.346 -39.933 -10.150 0.50 17.36 O Unresolved disorder model. using A ATOM 1470 OE2BGLU 180 19.295 -34.259 -9.205 0.50 18.84 O Unresolved disorder model. using A ATOM 1580 CA ALEU 195 10.376 -36.477 -2.842 0.70 15.91 C Unresolved disorder model. using A ATOM 1581 CA BLEU 195 10.380 -36.494 -2.852 0.30 15.13 C Unresolved disorder model. using A ATOM 1584 CB ALEU 195 10.868 -37.597 -1.921 0.70 15.55 C Unresolved disorder model. using A ATOM 1585 CB BLEU 195 10.898 -37.647 -1.994 0.30 14.90 C Unresolved disorder model. using A ATOM 1586 CG ALEU 195 9.824 -38.658 -1.552 0.70 17.07 C Unresolved disorder model. using A ATOM 1587 CG BLEU 195 11.050 -37.504 -0.481 0.30 14.40 C Unresolved disorder model. using A ATOM 1588 CD1ALEU 195 10.489 -39.942 -1.024 0.70 17.56 C Unresolved disorder model. using A ATOM 1589 CD1BLEU 195 9.796 -36.934 0.213 0.30 13.90 C Unresolved disorder model. using A ATOM 1590 CD2ALEU 195 8.818 -38.096 -0.524 0.70 18.07 C Unresolved disorder model. using A ATOM 1591 CD2BLEU 195 11.422 -38.861 0.085 0.30 14.37 C Unresolved disorder model. using A ATOM 1593 CA ALYS 196 13.412 -34.332 -3.741 0.50 14.90 C Unresolved disorder model. using A ATOM 1594 CA BLYS 196 13.397 -34.321 -3.695 0.50 15.40 C Unresolved disorder model. using A ATOM 1597 CB ALYS 196 14.534 -34.753 -4.688 0.50 14.70 C Unresolved disorder model. using A ATOM 1598 CB BLYS 196 14.632 -34.734 -4.492 0.50 15.39 C Unresolved disorder model. using A ATOM 1599 CG ALYS 196 15.384 -35.912 -4.177 0.50 14.72 C Unresolved disorder model. using A ATOM 1600 CG BLYS 196 15.655 -35.537 -3.660 0.50 15.65 C Unresolved disorder model. using A ATOM 1601 CD ALYS 196 16.676 -36.016 -4.961 0.50 12.95 C Unresolved disorder model. using A ATOM 1602 CD BLYS 196 16.875 -35.961 -4.500 0.50 16.73 C Unresolved disorder model. using A ATOM 1603 CE ALYS 196 16.552 -36.822 -6.214 0.50 10.59 C Unresolved disorder model. using A ATOM 1604 CE BLYS 196 17.894 -34.825 -4.592 0.50 18.05 C Unresolved disorder model. using A ATOM 1605 NZ ALYS 196 17.919 -36.875 -6.804 0.50 13.34 N Unresolved disorder model. using A ATOM 1606 NZ BLYS 196 19.098 -35.082 -5.462 0.50 19.25 N Unresolved disorder model. using A ATOM 1625 CA AARG 200 12.195 -27.874 -3.067 0.80 19.16 C Unresolved disorder model. using A ATOM 1626 CA BARG 200 12.213 -27.882 -3.125 0.20 18.71 C Unresolved disorder model. using A ATOM 1629 CB AARG 200 13.306 -28.289 -4.064 0.80 18.25 C Unresolved disorder model. using A ATOM 1630 CB BARG 200 13.170 -28.277 -4.270 0.20 18.42 C Unresolved disorder model. using A ATOM 1631 CG AARG 200 14.447 -29.025 -3.313 0.80 18.98 C Unresolved disorder model. using A ATOM 1632 CG BARG 200 14.273 -29.269 -3.915 0.20 19.15 C Unresolved disorder model. using A ATOM 1633 CD AARG 200 15.296 -30.007 -4.163 0.80 21.04 C Unresolved disorder model. using A ATOM 1634 CD BARG 200 15.367 -29.301 -5.005 0.20 18.44 C Unresolved disorder model. using A ATOM 1635 NE AARG 200 16.448 -30.474 -3.390 0.80 20.03 N Unresolved disorder model. using A ATOM 1636 NE BARG 200 16.086 -30.576 -5.100 0.20 20.33 N Unresolved disorder model. using A ATOM 1637 CZ AARG 200 16.418 -31.336 -2.357 0.80 22.66 C Unresolved disorder model. using A ATOM 1638 CZ BARG 200 16.921 -31.054 -4.179 0.20 20.75 C Unresolved disorder model. using A ATOM 1639 NH1AARG 200 15.249 -31.842 -1.922 0.80 15.64 N Unresolved disorder model. using A ATOM 1640 NH1BARG 200 17.147 -30.382 -3.055 0.20 21.53 N Unresolved disorder model. using A ATOM 1641 NH2AARG 200 17.576 -31.630 -1.706 0.80 17.61 N Unresolved disorder model. using A ATOM 1642 NH2BARG 200 17.531 -32.218 -4.373 0.20 20.75 N Unresolved disorder model. using A ATOM 1688 CA AVAL 206 2.405 -34.316 -11.270 0.50 20.50 C Unresolved disorder model. using A ATOM 1689 CA BVAL 206 2.391 -34.281 -11.302 0.50 20.99 C Unresolved disorder model. using A ATOM 1692 CB AVAL 206 3.406 -35.186 -10.475 0.50 20.30 C Unresolved disorder model. using A ATOM 1693 CB BVAL 206 3.548 -35.028 -10.587 0.50 20.91 C Unresolved disorder model. using A ATOM 1694 CG1AVAL 206 4.313 -36.008 -11.401 0.50 19.31 C Unresolved disorder model. using A ATOM 1695 CG1BVAL 206 3.054 -36.287 -9.863 0.50 20.21 C Unresolved disorder model. using A ATOM 1696 CG2AVAL 206 4.237 -34.316 -9.528 0.50 17.16 C Unresolved disorder model. using A ATOM 1697 CG2BVAL 206 4.659 -35.372 -11.584 0.50 20.28 C Unresolved disorder model. using A ATOM 1865 CA ALYS 229 -1.942 -35.262 -6.735 0.50 26.27 C Unresolved disorder model. using A ATOM 1866 CA BLYS 229 -1.940 -35.274 -6.721 0.50 26.35 C Unresolved disorder model. using A ATOM 1869 CB ALYS 229 -3.013 -34.295 -7.201 0.50 26.64 C Unresolved disorder model. using A ATOM 1870 CB BLYS 229 -3.080 -34.347 -7.118 0.50 26.71 C Unresolved disorder model. using A ATOM 1871 CG ALYS 229 -3.821 -33.675 -6.101 0.50 26.89 C Unresolved disorder model. using A ATOM 1872 CG BLYS 229 -4.118 -35.006 -8.013 0.50 27.48 C Unresolved disorder model. using A ATOM 1873 CD ALYS 229 -5.003 -32.973 -6.727 0.50 29.94 C Unresolved disorder model. using A ATOM 1874 CD BLYS 229 -5.427 -34.274 -7.917 0.50 29.12 C Unresolved disorder model. using A ATOM 1875 CE ALYS 229 -5.563 -31.947 -5.792 0.50 31.60 C Unresolved disorder model. using A ATOM 1876 CE BLYS 229 -6.435 -34.841 -8.891 0.50 30.57 C Unresolved disorder model. using A ATOM 1877 NZ ALYS 229 -6.128 -30.852 -6.603 0.50 32.28 N Unresolved disorder model. using A ATOM 1878 NZ BLYS 229 -7.667 -35.126 -8.142 0.50 32.25 N 1